Objective: Obesity is a condition that occurs as a result of excessive weight gain. Obesity is related with the
high risk of several diseases like cardiovascular diseases and diabetes mellitus. Elabela is a peptide that has
emerged recently and is known to affect food intake by binding to apelinergic receptors. This study aimed to
investigate the serum levels of Elabela in obese and non-obese individuals.
Material and Methods: This study involved 24 people with obesity and 25 healthy adult people as control
group. Height, weight, gender, age, waist-hip circumference, blood pressure of participants were recorded
and routine blood tests were measured. Serum concentrations of Elabela were determined using enzyme-
linked immunosorbent assay.
Results: When comparing the obese group to the controls, no statistically significant differences were observed
between the two groups in terms of diastolic blood pressure, blood urea nitrogen, creatinine, total
cholesterol, low density lipoprotein cholesterol and C-reactive protein. Similarly, both groups did not differ
statistically regarding Elabela levels. The obese group exhibited significantly elevated levels of body mass
index, waist/hip ratio, systolic blood pressure values, glucose, aspartate aminotransferase, alanine aminotransferase,
triglyceride, insulin, homeostatic model assessment for insulin resistance (HOMA-IR) compared
to the control group. The obese group demonstrated a significantly lower level of high-density lipoprotein
cholesterol in comparison to the control group.
Conclusion: In this study, it was found that there was no relationship between Elabela levels and obesity.
However, this issue needs to be supported by further studies to clarify.
Evaluation of Elabela Levels in Obese Individuals OBEZ BIREYLERDE ELABELA DÜZEYLERİNİN DEĞERLENDİRİLMESİ Evaluation of Elabela Levels in Obese Individuals OBEZ BIREYLERDE ELABELA DÜZEYLERİNİN DEĞERLENDİRİLMESİ
Birincil Dil | Türkçe |
---|---|
Konular | Tıbbi Biyokimya ve Metabolomik (Diğer) |
Bölüm | Orjinal Çalışma |
Yazarlar | |
Yayımlanma Tarihi | 14 Haziran 2024 |
Gönderilme Tarihi | 1 Haziran 2024 |
Kabul Tarihi | 2 Haziran 2024 |
Yayımlandığı Sayı | Yıl 2024 Cilt: 14 Sayı: 2 |